AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualitative detection of IgG antibodies against HEp2 cells in human serum. Each well is coated with lysed HEp2 cells. The test collectively detects, in one well, total ANAs against double stranded DNA (dsDNA), histones, SS-A (Ro), SS-B (La), Sm, snRNP/Sm, Scl-70, PM-Scl, Jo-1 and centromeric antigens along with sera positive for HEp2 immunofluorescence test (IFT). The assay is a tool in the diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren`s syndrome, polymyositis and dermatomyositis. 30'+30'+30' automation incubation.

AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualitative detection of IgG antibodies against HEp2 cells in human serum. Each well is coated with lysed HEp2 cells. The test collectively detects, in one well, total ANAs against double stranded DNA (dsDNA), histones, SS-A (Ro), SS-B (La), Sm, snRNP/Sm, Scl-70, PM-Scl, Jo-1 and centromeric antigens along with sera positive for HEp2 immunofluorescence test (IFT). The assay is a tool in the diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren`s syndrome, polymyositis and dermatomyositis.

AESKUSLIDES ANA-HEp-2 is an indirect immunofluorescence assay to detect nuclear and / or cytoplasmic autoantibodies in human serum. The assay is a tool in the differential diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren’s syndrome (SS), polymyositis and dermatomyositis.

AESKUSLIDES ANA-HEp-2 is an indirect immunofluorescence assay to detect nuclear and / or cytoplasmic autoantibodies in human serum. The assay is a tool in the differential diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren’s syndrome (SS), polymyositis and dermatomyositis.

AESKUSLIDES® ANA HEp-2-Gamma is an indirect fluorescent antibody assay utilizing HEp-2 cell coated slides as a substrate for the qualitative and/or semi-quantitative determination of antinuclear antibodies (ANA) in human serum.

AESKULISA ANA-HEp-2 is a solid phase enzyme immunoassay for the combined qualitative detection of IgG antibodies against HEp2 cells in human serum. Each well is coated with lysed HEp2 cells. The test collectively detects, in one well, total ANAs against double stranded DNA (dsDNA), histones, SS-A (Ro), SS-B (La), Sm, snRNP/Sm, Scl-70, PM-Scl, Jo-1 and centromeric antigens along with sera positive for HEp2 immunofluorescence test (IFT). The assay is a tool in the diagnosis of systemic rheumatic diseases like systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjögren`s syndrome, polymyositis and dermatomyositis.

Automated system for immunofluorescence processing with an integrated fluorescence microscope and software for routine laboratory use by professional users under controlled environmental conditions.

Automated system for immunofluorescence processing with an integral fluorescence microscope and software for routine laboratory use by professional users under controlled environmental conditions.

Antinuclear Antibody (ANA) Test Kit

Antinuclear Antibody (ANA) Test Kit

Antinuclear Antibody (ANA) Test Kit

Anti-nDNA Antibody Test Kit

1. 10x 6-well HEp 2 ANA Substrate Slides2. 1x 1mL Homo. Ptn. (use w/Conj. 504070 or 504088)3. 1x mL Centromere Positive Control4. 1x 1mL IFA System Negative Control5. 1x 7mL FITC IgG (H&L) HEp Conjugate6. 1x 3mL PVA Mounting Medium7. 2x 25mL PBS II Concentrate (40x)8. 1x 3mL 1% Evans Blue9. 1x 10 Coverslips

1. 20x 12-well HEp 2 ANA Substrate Slides2. 1x 1mL Homo. Ptn. (use w/Conj. 504070 or 504088)3. 1x 1 mL Centromere Positive Control4. 1x 1mL IFA System Negative Control5. 1x 15mL FITC IgG (H&L) HEp Conjugate7. 1x 10mL PVA Mounting Medium8. 2x 25mL PBS II Concentrate (40x)9. 1x 3mL 1% Evans Blue10.1x 20 Coverslips

1. 20x ANA Hep- 2 -QR Slide (12 well)2. 1x 0.5mL IFA System Negative Control3. 1x 15mL FITC IgG Conjugate with DAPI 4. 1x 7mL Mounting Medium5. 2x 25mL PBS II Concentrate (40x)6 .1x Coverlips, 20 each7. 1x 0.5mL ANA Titratable Pattern

1. 10x 6-well dsDNA Crithidia luciliae Substrate Slides2. 1x 4mL FITC Anti Human IgG Conjugate 3. 1x 0.5 mL dsDNA Positive4. 1x 0.5mL IFA System Negative Control5. 1x 25mL PBS II Concentrate (40x)6. 1x 7mL Mounting Medium7. 1x 10 Coverslips

1. 20x 12-well dsDNA Crithidia luciliae Substrate Slides2. 1x 15mL FITC Anti Human IgG Conjugate 3. 1x 0.5 mL dsDNA Positive4. 1x 0.5mL IFA System Negative Control5. 2x 25mL PBS II Concentrate (40x)6. 1x 7mL Mounting Medium7. 1x 20 Coverslips

1. 20x 12-well bar-coded dsDNA Crithidia luciliae Substrate Slides2. 1x 15mL FITC Anti Human IgG Conjugate with DAPI3. 1x 0.5 mL dsDNA Positive Control4. 1x 0.5mL IFA System Negative Control5. 2x 25mL PBS II Concentrate (40x)6. 1x 7mL Mounting Medium7. 1x 20 Coverslips

1. 25x 8-well ANA KSL Substrate Slides2. 1x 15mL FITC Anti-Human IgG Conjugate3. 1x 1.0mL ANA Homogeneous Pattern4. 1x 1.0mL IFA System Negative Control5. 2x 25mL PBS Concentrate (40x)6. 1x 10mL Mounting Medium7. 1x 25 Coverslips

1. 10x 4-well ANA KSL Substrate Slides2. 1x 7mL FITC Anti Human IgG Conjugate 3. 1x 0.5 mL ANA Homogeneous Pattern4. 1x 0.5mL IFA System Negative Control5. 1x 25mL PBS Concentrate (40x)6. 1x 7mL Mounting Medium7. 1x 10 Coverslips